Ablation of atrial fibrillation and risk of stroke: A meta-analysis

Rui Providencia1, Hussam Ali2, Sérgio Barra3

  • 1Institute of Health Informatics Research, University College London, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.

Heart Rhythm
|May 21, 2025
PubMed

Insights

Catheter ablation significantly reduces stroke risk in patients with atrial fibrillation (AF) despite anticoagulant therapy. Further trials are needed to confirm this stroke protection benefit.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Interventions

Background:

  • Patients with atrial fibrillation (AF) face a persistent stroke risk even with anticoagulant treatment.
  • The additional stroke protection offered by catheter ablation in AF patients requires further investigation.

Purpose of the Study:

  • To evaluate the stroke-protective benefits of catheter ablation for atrial fibrillation (AF).

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing catheter ablation to medical treatment in AF patients.
  • Data from 18 RCTs involving 5877 patients were pooled to calculate relative risks and number needed to treat.
  • Quality of evidence was assessed using GRADE, with subgroup analyses performed on various patient and study characteristics.

Main Results:

  • Catheter ablation demonstrated a significant reduction in stroke risk (RR 0.63; P = .006) with a number needed to treat of 78.7.
  • Moderate quality evidence showed low heterogeneity (I² = 0) across studies.
  • Subgroup analyses indicated consistent stroke risk reduction, except in trials with less than one year of follow-up.

Conclusions:

  • Pooled data from high-quality RCTs suggest catheter ablation offers significant stroke risk reduction in AF patients.
  • While promising, a definitive answer requires a dedicated confirmatory trial.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...